Heart Failure & Congestion
Connect symptoms and examination with cardiac structure, volume status and a monitored treatment plan.
20 learning units • 100 chapter sections • 200 explained questions. Assess the patient, choose investigations and build a monitored management plan across adult medical specialties.
Connect symptoms and examination with cardiac structure, volume status and a monitored treatment plan.
Quick revision ↓ Medical Dictionary
Exertional breathlessness, orthopnoea, fatigue and swelling may indicate heart failure, but none is specific. Examine jugular venous pressure, lung crepitations, peripheral oedema, perfusion and the cardiac impulse. Consider kidney, liver, pulmonary and venous causes. Distinguish a congested patient with preserved perfusion from someone with shock; the same complaint of breathlessness can require very different immediate treatment and escalation.
ECG, natriuretic peptides and echocardiography support assessment, with further tests directed at cause and severity. Natriuretic peptides are influenced by age, renal dysfunction, rhythm and obesity and are not interpreted alone. Echocardiography evaluates ejection fraction, valves and structure. Preserved ejection fraction does not exclude heart failure, which requires evidence consistent with the syndrome and abnormal filling or cardiac function.
Acute deterioration may follow myocardial ischaemia, arrhythmia, infection, uncontrolled blood pressure, renal dysfunction or interruption of treatment. Review salt and fluid intake, medicines that promote retention, and adherence barriers. Compare weight and exercise capacity with baseline. Treating congestion while missing the precipitating cause can produce only temporary improvement, so diagnostic review and symptom relief should proceed together.
Urgent care is guided by oxygenation, congestion and perfusion. Diuretic treatment for fluid overload requires monitoring of symptoms, urine output, weight, electrolytes and kidney function. Respiratory support or critical-care input may be needed for pulmonary oedema and instability. Routine large fluid boluses can worsen congestion; suspected depletion requires a careful assessment and review of response rather than a fixed rule for every patient.
For reduced-ejection-fraction disease, guideline-directed therapy commonly combines complementary drug classes, adjusted for blood pressure, kidney function and potassium. Treatment of preserved-ejection-fraction disease also addresses congestion, comorbidity and eligible disease-modifying therapy. Check the current specialist pathway before prescribing. Agree monitoring, education on worsening symptoms, rehabilitation where appropriate and a practical review schedule. Symptom improvement does not justify stopping all long-term treatment.
Read the relevant guideline sections alongside these original clinical teaching cases. Local pathways, available services and individual patient factors determine care.
Reference review: 27 September 2026. Consult current local protocols for prescribing, procedures and escalation.